Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urination Disorders 1Urinary Bladder, Overactive 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × Solifenacin Succinate × Clear all
NCT01777217 2015-01-16

VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

Advanced Research Network

Phase 4 Terminated
8 enrolled 6 charts
Genitourinary

Urination Disorders, Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡